ROME — Rome Health is expanding its robotic surgery program to provide men with a new minimally invasive option to treat an ...

Rome Health is expanding its robotic surgery program to offer a new minimally invasive option for treating an enlarged ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

Halda to be acquired by Johnson & Johnson for $3.05 billion in cashHalda recently presented positive Phase 1/2 data for ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ...

And what can you expect during your visit? Two urologists have answers:According to Dr Axel Merseburger, spokesman for the German Society for Urology (DGU), a man should see a urologist in cases of ...

In a significant move within the biotechnology sector, Halda Therapeutics announced today that it has entered into a definitive agreement for its acquisition by Johnson & Johnson for $3.05 billion in ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...

HuonsN, a life care solutions company under the Huons Group, has strengthened its production capabilities by acquiring BioLoget, a manufacturer of ...

Malcolm LaVergne, executor of Simpson’s estate, has accepted Fred Goldman’s creditor claim for $57,997,858.12, plus 30 years ...